Educations

President Obama Announces Efforts to Address Opioid Epidemic

Dr. Brad Hall, DFASAM, President of the West Virginia ASAM chapter, and Penny Mills, CEO of ASAM, attended community discussion on the prescription drug abuse and heroin epidemic led by President Barack Obama in Charleston, West Virginia.

Educations

Dr. Beny J. Primm: Pioneer in Research, Treatment of Addiction and Co-Occurring Disorders

"For 50 years, ASAM member Dr. Primm had been on the front lines in the use of medication in treating opioid dependence" writes Dr. Lawrence Brown, Jr, MPH, DFASAM.

Educations

Repurposing Medications to Treat Addiction?

If researchers can get access to test new medications that have been developed and tested in human clinical trials for other non-addiction conditions, they could be proven effective for addiction treatment.

Educations

ASAM Testifies to House Subcommittee on the Use of Medication in Addiction Treatment

Dr. Corey Waller, Chair of the Legislative Advocacy Committee, testified on behalf of ASAM at the House Energy and Commerce Subcommittee on Health for a hearing reviewing legislative proposals to combat the national drug abuse crisis.

Educations

Setting a New Standard for Treatment with Five-Year Recovery

A new standard of five-year recovery has the potential to dramatically improve the way in which SUDs are managed, changing clinical practice and changing treatment outcome research.

Educations

Survey Results: Addiction Specialists Weigh In on the DATA 2000 Patient Limits

ASAM survey of addiction specialists indicate patient demand for opioid addiction treatment has increased. Two-thirds of specialists report demand for buprenorphine treatment exceeds the 100-patient limit.

Educations

Join ASAM in the National Day of Giving

ASAM has joined #GivingTuesday, a global day of giving that harnesses the collective power of individuals, communities and organizations to encourage philanthropy and to celebrate generosity worldwide.

Educations

ASAM's Dr. Soper to Join CDC Director Tom Frieden at AMA Opioid Epidemic Event

On Monday, November 16, ASAM's Dr. Richard Soper will take the stage at the AMA Interim Meeting in Atlanta to discuss stigma related to addiction.

Educations

Advocacy Action Alert! Tell the White House the FDA should regulate all tobacco products

Educations

ASAM National Practice Guideline Stakeholder Summit Held

More than ten medical societies, eight federal agencies and other patient and payer organizations met on September 24 to discuss strategies to help accelerate the adoption of ASAM's newly released <em>National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use.</em>

Educations

Leadership Profile: Margaret A. E. Jarvis, MD, FASAM

Margaret Jarvis, MD, FASAM, who is the Chair of the Quality Improvement Council, recently oversaw the development of ASAM's <em>National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use.</em>

Educations

Creating a National Policy for State-level Debate

Leading the writing committee to draft the “ASAM Public Policy Statement on Marijuana, Cannabinoids and Legalization” presented some unique challenges, writes Michael Miller, MD, FASAM, FAPA, in an Op-Ed about his role in revising ASAM's marijuana public policy statement.

Educations

Ask the PCSS Expert: Fentanyl Patches and Induction?

A physician wrote the PCSS mentor network seeking advice and recommendations on buprenorphine induction for patients on Fentanyl patches.

Educations

Host Compassionate Conversations on Addiction in Your Home

Host compassionate conversations about addiction in your home with Drugs Over Dinner.

Educations

Seattle’s LEAD Project – A Different Approach with Low-Level Drug Offenders

Implemented on a pilot basis in Seattle, Washington in 2011, Law Enforcement Assisted Diversion (LEAD) was designed to finally truly integrate a public health approach into policing of street level drug use and sales (and concomitant behaviors such as street based sex work).

Educations

CMS Issues 1115 Waiver Mentioning ASAM's Criteria

Medicaid is playing an increasingly important role as a payer for services provided to individuals with addiction in the United States. There have been some exciting developments regarding The ASAM Criteria in Medicaid's expanding role......"exciting" for me anyway, because I have been on a mission for 25 years to have The ASAM Criteria accepted as the model for addiction treatment's continuum of care.

Educations

2016 Ruth Fox Scholarship Open to Applicants

The Ruth Fox scholarship program was started to encourage emerging physicians-in-training to pursue the addiction medicine field. It is important for ASAM to provide the education for these new physicians to identify and treat patients with addictive disorders because many medical schools do not include addiction medicine coursework or rotations.

Educations

ASAM Issues New Policy Statement on Marijuana, Cannabinoids and Legalization

The new policy statement addresses the broad public health and safety aspects of current efforts to legalize marijuana use.

Educations

National Practice Guideline and Associated Products at Press Conference and Stakeholder Summit

ASAM convened stakeholders, including several medical societies, eight federal agencies, patient and payers organizations at the National Press Club in Washington, DC, for a press conference and stakeholder summit to announce and accelerate the adoption of its newly released National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use (National Practice Guideline) and associated products.

Educations

Marijuana, Cannabinoids and Legalization